Study on MB-CART2019.1 for Treating Relapsed or Hard-to-Treat Diffuse Large B Cell Lymphoma (DLBCL) | Clinical Trial

Study on MB-CART2019.1 for Treating Relapsed or Hard-to-Treat Diffuse Large B Cell Lymphoma (DLBCL) | Clinical Trial | Right2Hope